Pharmaceuticals

Global Montelukast Sodium Market Analysis 2025–2029: Opportunities for Strategic Growth

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Montelukast Sodium Market Expected To Become By 2029 Compared With Its 2025 Level?

The montelukast sodium market has experienced significant expansion over recent years. It is projected to increase from $3.86 billion in 2024 to $4.2 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.9%. The market’s historical development is attributable to factors such as a rise in respiratory conditions, an increasing elderly population, escalating air pollution levels, enhanced awareness and education, and its growth into new emerging markets.

The montelukast sodium market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $5.89 billion by 2029, achieving a compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period stems from factors such as new approvals and product launches, ongoing clinical studies, the expiration of patents, evolving regulatory landscapes, and shifts in physician prescribing habits. Key trends anticipated within this timeframe involve heightened generic competition, a move towards combined treatment approaches, market expansion into developing regions, a greater emphasis on pediatric applications, and the integration of digital health solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

Which Drivers Are Supporting Growth Of The Montelukast Sodium Market?

The montelukast sodium market is projected to grow due to the increasing incidence of asthma. Asthma is a chronic respiratory condition characterized by inflammation and constriction of the airways, leading to recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing. The rise in asthma prevalence is linked to environmental pollution, allergen exposure, genetic predisposition, urbanization, lifestyle changes, and respiratory infections. Montelukast sodium is utilized in asthma as a leukotriene receptor antagonist, aiding in the prevention and management of asthma symptoms by blocking leukotrienes, which contribute to airway inflammation and narrowing. For instance, in July 2024, the American Lung Association, a US-based voluntary health organization, stated that in 2022, approximately 44.2 million Americans, or 13.5% of the population, had been diagnosed with asthma by a healthcare professional. Therefore, the expanding prevalence of asthma is driving the growth of the montelukast sodium market.

What Are The Segment Types Shaping The Montelukast Sodium Market?

The montelukast sodium market covered in this report is segmented –

1) By Product: Crystal-like, Form-less Or Amorphous

2) By Dosage Form: Tablets, Oral Solutions

3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Subsegments:

1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium

2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

What Long-Term Trends Will Shape The Future Growth Of The Montelukast Sodium Industry?

Major companies within the montelukast sodium market are developing new medications, such as over-the-counter generic drugs, to provide more convenient treatment options for patients managing asthma and allergic rhinitis. Over-the-counter (OTC) generic medications are products available for purchase without a prescription, commonly found in pharmacies or retail stores. For instance, in July 2022, Dr. Reddy’s Laboratories, an India-based pharmaceutical company, introduced Fexofenadine HCL 180 mg and Pseudoephedrine HCl 240 mg in the US. This specific medication is intended for the temporary relief of nasal and sinus congestion resulting from colds or allergies. Equivalent to Allegra-D 24 HR, it combines an antihistamine and nasal decongestant to relieve symptoms including sneezing, runny nose, itchy eyes, and throat. Offered in 5, 10, and 15-count pack sizes, it provides a high-quality, cost-effective solution for individuals seeking comfort from upper respiratory discomfort.

Which Leading Players Are Enhancing Their Montelukast Sodium Market Presence Worldwide?

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Montelukast Sodium Market?

North America was the largest region in the montelukast sodium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Montelukast Sodium Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16123&type=smp

Browse Through More Reports Similar to the Global Montelukast Sodium Market 2025, By The Business Research Company

Sodium Cocoyl Isethionate Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sodium-cocoyl-isethionate-global-market-report

Sodium Reduction Ingredients Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sodium-reduction-ingredients-global-market-report

Sodium Lauryl Ether Sulfate Sles Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sodium-lauryl-ether-sulfate-sles-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795